Presentation Information
[OE4-3]Different clinical effect of two RP1L1 hotspots of East Asian Patients with Occult Macular Dystrophy; EAOMD Report No.4
○Yu Fujinami-Yokokawa1,2,3, Seong Joon Ahn4, Kwangsic Joo5, Kazushige Tsunoda6, Mineo Kondo7, Hui Li8, Kyu Hyung Park5, Izumi Naka9, Jun Ohashi7, Hisateru Tachimori10, Hiroaki Miyata2, Se Joon Woo5, Ruifang Sui8, Kaoru Fujinami1,3 (1.Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan, 2.Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan, 3.UCL Institute of Ophthalmology, London, UK, 4.Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea, 5.Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea, 6.Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan, 7.Department of Ophthalmology, Mie University Graduate School of Medicine, Mie, Japan, 8.Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, 9.Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Japan, 10.Endowed Course for Health System Innovation, Keio University School of Medicine, Tokyo, Japan)